Stay updated on VenDex vs PomDex in t(11;14)+ MM Clinical Trial
Sign up to get notified when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.

Latest updates to the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now displays related topics: ‘Multiple myeloma’ under MedlinePlus Genetics, providing additional contextual navigation. This is a minor informational enhancement that does not alter the study details themselves.SummaryDifference0.1%

- Check14 days agoChange DetectedThe Locations section now lists a broad set of study sites across the United States, Canada, Europe, and other regions, expanding the geographic footprint of the trial.SummaryDifference4%

- Check22 days agoChange DetectedPublications section updated with a PubMed citation for the CANOVA primary results (J Clin Oncol, 2025). The update does not modify study design, eligibility, or endpoints.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page no longer displays the topic 'Multiple Myeloma' and the related 'MedlinePlus Genetics' link. This reduces disease context and access to related resources for users.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.1 on the page. No changes to study details, eligibility criteria, or locations are evident.SummaryDifference0.6%

Stay in the know with updates to VenDex vs PomDex in t(11;14)+ MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.